Table 3.
Chemokine/ Chemokine Receptor |
Inhibitory Strategy | Species (Mice or Rats) | Model | Beneficial Effects | References |
---|---|---|---|---|---|
CCL8 | Anti-CCL8 in early CKD | Mice | Uremic cardiomyopathy induced by 5/6 nephrectomy. | ↓ Attenuated infiltration of TCD4+, lymphocytes and macrophages. ↓ Cardiac remodeling. ↓ Inflammation. ↓ Cardiac dysfunction. |
[52] |
CXCL10 | CCR2-/- mice or Anti-CXCL10 antibody |
Mice | Uremic cardiomyopathy induced by 5/6 nephrectomy or intraperitoneal folate (240 mg/kg body weight). | ↓ Monocyte infiltration in the heart. ↓ Cardiac alterations. ↓ Macrophage local proliferation. ↓ Cardiac hypertrophy. ↓ Cardiac dysfunction. |
[53] |
Abbreviations: CKD: chronic kidney disease, CCL8: C-C motif chemokine 8, CXCL10: chemokine (C-X-C motif) ligand (CXCL)10. Symbols: ↓ decrease.